renal cell carcinoma	is a histologic subtype of	kidney cancer
clear cell RCC	is a histologic subtype of	renal cell carcinoma
papillary RCC	is a histologic subtype of	renal cell carcinoma
chromophobe RCC	is a histologic subtype of	renal cell carcinoma
renal pelvis urothelial carcinoma	is a histologic subtype of	renal pelvis cancer
kidney cancer	metastasizes to	lungs
kidney cancer	metastasizes to	liver
kidney cancer	metastasizes to	bone
kidney cancer	metastasizes to	brain
renal pelvis cancer	metastasizes to	lymph nodes
kidney cancer	presents with	hematuria
kidney cancer	presents with	flank pain
kidney cancer	presents with	weight loss
renal pelvis cancer	presents with	hematuria
renal pelvis cancer	presents with	urinary obstruction
paraneoplastic syndrome	includes	hypercalcemia
paraneoplastic syndrome	includes	erythrocytosis
hypercalcemia	is a	paraneoplastic syndrome associated with kidney cancer
erythrocytosis	is a	paraneoplastic syndrome associated with kidney cancer
smoking	increases risk of	kidney cancer
obesity	increases risk of	kidney cancer
hypertension	increases risk of	kidney cancer
polycystic kidney disease	increases risk of	kidney cancer
men	have higher risk for	kidney cancer
kidney cancer	is more common in	men
kidney cancer	occurs at	older age
sunitinib	is a	tyrosine kinase inhibitor
pazopanib	is a	tyrosine kinase inhibitor
axitinib	is a	tyrosine kinase inhibitor
cabozantinib	is a	tyrosine kinase inhibitor
nivolumab	is a	PD-1 inhibitor
pembrolizumab	is a	PD-1 inhibitor
everolimus	is a	mTOR inhibitor
temsirolimus	is a	mTOR inhibitor
bevacizumab	is a	VEGF inhibitor
renal cell carcinoma	is treated with	nephrectomy
localized kidney cancer	is treated with	partial nephrectomy
localized kidney cancer	is treated with	radical nephrectomy
small renal mass	is treated with	cryoablation
small renal mass	is treated with	radiofrequency ablation
renal pelvis cancer	is treated with	nephroureterectomy
nephroureterectomy	is a	surgical procedure
partial nephrectomy	is a	surgical procedure
radical nephrectomy	is a	surgical procedure
cryoablation	is a	treatment modality
radiofrequency ablation	is a	treatment modality
adjuvant therapy	is used for	renal cell carcinoma
neoadjuvant therapy	is used for	renal cell carcinoma
stage I	is a	stage of kidney cancer
stage IV	is a	stage of kidney cancer
TNM stage	determines	prognosis
Fuhrman grade	determines	prognosis
ISUP grade	determines	prognosis
vascular invasion	indicates	aggressive tumor
lymph node involvement	worsens	prognosis
tumor necrosis	is a	adverse histologic feature
tumor size	correlates with	prognosis
negative surgical margins	indicate	complete resection
positive surgical margins	indicate	residual tumor
lymph node dissection	is a	surgical procedure
performance status	predicts	survival
hypercalcemia	is a	paraneoplastic phenomenon associated with kidney cancer
liver metastasis	is a	metastatic site
lung metastasis	is a	metastatic site
bone metastasis	is a	metastatic site
brain metastasis	is a	metastatic site
advanced disease	has	poor prognosis
late stage disease	has	poor prognosis
overall survival	is affected by	stage
progression-free survival	improves with	sunitinib
progression-free survival	improves with	pazopanib
overall survival	improves with	nivolumab
time to progression	lengthens with	cabozantinib
nephrectomy	reduces	tumor burden
radical nephrectomy	reduces	tumor burden
partial nephrectomy	preserves	renal function
nephron-sparing surgery	preserves	renal function
metastatic kidney cancer	requires	systemic therapy
systemic therapy	is used for	metastatic kidney cancer
clinical trial	offers	novel therapy
bevacizumab	is used for	metastatic kidney cancer
checkpoint inhibitors	are	immunotherapy agents
immunotherapy	includes	checkpoint inhibitors
VEGF inhibitors	are	targeted therapy
PD-1 inhibitors	are	immunotherapy
renal cell carcinoma	prognosis depends on	stage
renal cell carcinoma	prognosis depends on	performance status
urine cytology	is used for	urothelial carcinoma detection
imaging	is essential for	cancer staging
biopsy	confirms	histology
tumor grade	guides	prognosis
nephrectomy	facilitates	staging and treatment planning
renal function	declines after	nephrectomy
nephrectomy	affects	renal function
postoperative renal function	recovers	gradually
cancer-related fatigue	is a	common symptom in kidney cancer
anemia	may occur in	advanced kidney cancer
dialysis	may be required for	kidney cancer with CKD
survival	is predicted by	stage
survival	is predicted by	performance status
